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ABSTRACT                        The term zygomycosis refers to a diverse group of mycotic diseases caused by 
members of the orders Mucorales and Entomophthorales. These infections are frequently as-
sociated with diabetic ketoacidosis, deferoxamine treatment, cancer and its therapy, solid or-
gan or bone marrow transplantations, extreme malnutrition and neutropenia. Although these 
mycoses are relatively rare, their high mortality rate underline the importance of this group 
of fungal infections. Molecular techniques are widely used to identify the virulence factors of 
clinically important fungi or to develop useful diagnostic techniques. However, application of 
these methods to characterize the opportunistic pathogenic nature of zygomycetes started only 
a few years ago. This review discusses the current state of molecular studies performed on the 
pathogenicity and diagnosis of zygomycetes causing opportunistic human mycosis.
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Zygomycetes fungi are characterized by the presence of 
aseptate wide hyphae (coenocytic mycelia) and the formation 
of zygospores. They are saprophytic filamentous fungi which 
are ubiquitous in soil and decaying organic materials. Several 
species belonging in the orders Mucorales and Entomophtho-
rales have been reported to be agents of opportunistic human 
mycoses, designated as zygomycosis (mucormycosis).
Within the Mucorales, Rhizopus seems to be most fre-
quently involved in zygomycoses, but Absidia, Rhizomucor, 
Mucor, Apophysomyces, Saksanea, Cunninghamella, Cokero-
myces and Syncephalastrum species have also been isolated 
from clinical specimens (Ribes et al. 2000; Eucker et al. 2001; 
Freifeld and Iwen 2004); in fact, non-Rhizopus species are 
being increasingly recognized as causative agents of opportu-
nistic mycoses (Walsh and Groll 1999). Healthy humans are 
generally unaffected, but those with weakened immunity are 
at risk of infection. The major risk factors for the develop-
ment of zygomycosis are diabetic ketoacidosis; deferoxamine 
treatment to manage an iron or aluminium overload; cancer 
and its therapy; solid organ or bone marrow transplantations; 
prolonged steroid use; and extreme malnutrition or neutro-
penia (Ribes et al. 2000; Nucci 2003; Walsh et al. 2004). 
The spores produced by these fungi are airborne and can be 
inhaled into the respiratory tract: this is the most common 
route for the infection of a susceptible host. Zygomycoses 
manifest primarily as rhinocerebral infections, but pulmonary 
and disseminated mycoses also occur, as do gastrointestinal 
and subcutaneous infections and allergic diseases. 70% of 
rhinocerebral infections, which account for from one-third 
to one-half of all zygomycoses, are associated with diabetic 
ketoacidosis (Ribes et al. 2000). Rhinocerebral disease has 
a high mortality rate, but curation is possible (depending on 
the state of the patient) if an early diagnosis is followed by 
aggressive surgical and antifungal treatment.
Conidiobolus and Basidiobolus species, from the order 
Enthomophthorales, generally cause subcutaneous and mu-
cocutaneous infections in tropical and subtropical areas.
The diagnosis of zygomycoses is very challenging: most 
such infections are identified only as zygomycosis or mu-
cormycosis, without species or at least genus determination 
(Ribes et al. 2000; Eucker et al. 2001; Freifeld and Iwen 
2004). Currently, the definitive diagnosis of zygomycosis is 
achieved by biopsy and histological study of the tissue lesions 
(Freifeld and Iwen 2004; Walsh et al. 2004). Culturing of an 
isolate from a tissue sample could be of help for the species 
identification. However, this is often difficult, because hyphal 
elements may be rare in tissue specimens and they can lose 
their viability during the tissue homogenization prior to cul-
turing. Whenever an isolate is successfully isolated from a 
clinical sample, it is very important to maintain it for further 
analysis. Simple strain maintenance methods are well estab-
lished for the zygomycetes (Palágyi et al. 1997) and can be 
easily carried out in clinical laboratories. Attempts have been 
made to elaborate diagnostic methods based on molecular 
and antigen detection techniques (Jones and Kaufman 1978; 
Hessian and Smith 1982; Pierce et al. 1982; Yankey and Abra-
ham 1983; Kaufman et al. 1989; Zeilander et al. 1990; Voigt 
et al. 1999; Wu et al. 2003), but all of them are still in the 
experimental phase and are not yet used in clinical practice 
(Ribes et al. 2000).
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Although high doses are needed for successful therapy, 
amphotericin B is the classical antifungal agent of choice for 
the treatment of zygomycosis. Currently available triazoles 
have proved to be inactive as sole antifungal agent against 
zygomycetes (Garas et al. 1999; Tawara et al. 2000; Sun et 
al. 2002a). An exception is posaconazole, which exhibits 
activity in vitro, in animal models and in some patients 
(Sun et al. 2002b; Tobon et al. 2003). Applications of drug 
combinations for this fungal group are weakly documented. 
Surgical intervention is a standard part of the treatment of 
localized infections.
The high mortality rate (75-95%, depending on the form 
of the zygomycosis) and the fact that these fungi display 
intrinsic resistance to the most widely used antifungal drugs 
underline the importance of this group of fungal infections 
(Ribes et al. 2000; Eucker et al. 2001).
In the past decade, advances in fungal biology have made 
molecular techniques essential in the study of medically 
important fungi. These methods are used to identify their 
virulence factors, to determine new therapeutic targets or to 
develop useful diagnostic techniques. Although molecular 
methods are relatively well established for the zygomycetes, 
and especially for the genus Mucor, application of these tech-
niques to study the opportunistic pathogenic nature of these 
fungi started only a few years ago. We review here the current 
state of pathogenic and diagnostic studies on clinically impor-
tant zygomycetes, based on molecular genetic approaches.
Molecular taxonomy and strain typing 
Techniques used in taxonomic studies and genotyping, such 
as PCR with species-specific primers, hybridizations with 
specific probes, mitochondrial and genomic restriction frag-
ment length polymorphism (RFLP), sequence analysis of the 
ribosomal DNA and/or the internal transcribed spacer (ITS) 
region, single-strand conformational polymorphism (SSCP), 
random amplified polymorphic DNA (RAPD) and pulsed 
field gel electrophoresis (PFGE), could serve as the basis for 
the development of rapid and specific DNA-based methods 
for the clinical diagnosis; moreover, molecular genotyping 
could reveal important data concerning the epidemiology of 
these infections.
Ribosomal DNA (rDNA) and some other gene sequences 
(such as actin and elongation factor 1) have been successfully 
used to reveal the phylogenetic relationships within the orders 
Mucorales (Voigt et al. 1999; O’Donnell et al. 2001; Voigt and 
Wöstemeyer 2001; Papp et al. 2003a) and Entomophthorales 
(Jensen et al. 1998). The results of these studies suggest that 
zygomycete systematics based primarily on morphological 
characteristics is highly artificial and a complete revision 
appears indicated (Nagy et al. 2004b). A number of markers 
have been identified that are potentially useful for further 
studies aimed at the development of diagnostic methods.
In contrast with the detailed phylogenetic studies on 
higher taxonomic levels, intraspecific genetic polymorphisms 
have been analyzed only relatively rarely in the zygomycetes. 
The taxonomic positions of several Rhizomucor strains have 
been determined and evaluated by ITS-RFLP (Vastag et al. 
1998a; Vágvölgyi et al. 1999). On this basis, isolates were 
clearly demonstrated to be members of either R. miehei or 
R. pusillus; surprisingly, the single isolate of R. tauricus 
was identified as a mutant heterothallic R. pusillus strain. 
ITS-RFLP also distinguished Apophysomyces elegans, an 
emerging agent of zygomycosis with an increasing number 
of cases in India, from other clinically important zygomyce-
tes, but the method was not able to demonstrate intraspecific 
polymorphism (Chakrabarti et al. 2003); microsatellite PCR 
fingerprinting was used to resolve this problem. ITS-RFLP 
and PCR fingerprinting allowed differentiation among the 
isolates of Cunninghamella echinulata and C. bertholletiae 
(Lemmer et al. 2002).
Among the varoius RFLP techniques, restriction patterns 
of mtDNA are frequently used in fungal taxonomy and ge-
notyping, because this sensitive method indicates differences 
at a specific and even an intraspecific level. However, in the 
Zygomycetes, only the mtDNA organization of individual 
isolates of a few species have been reported, i.e. M. racemosus 
(Schramke and Orlowski 1993), M. piriformis (Papp et al. 
1999), R. stolonifer (Paquin et al. 1997), R. oryzae, Mortier-
ella verticillata and Smittium culisetae (Seif et al. 2005).
PFGE is also a versatile tool for molecular typing and to 
reveal the genetic variability at species and intraspecies levels. 
In the past 15 years, karyotypes of several zygomycetes, such 
as Mucor circinelloides (Vágvölgyi and Manczinger 1990; 
Nagy et al. 1994; Diaz-Minguez et al. 1999), M. bainieri, 
M. mucedo, M. plumbeus, M. racemosus (Nagy et al. 2000), 
Parasitella parasitica (Burmester and Wöstemeyer 1994) and 
species belonging in the genus Micromucor (Nagy et al. 2004) 
have been established. However, only a few data concerning 
opportunistic zygomycetes have been reported to date. The 
karyotypes of Absidia glauca strains have been revealed by 
rotating field gel electrophoresis (Kayser and Wöstemeyer 
1991). Isolates with different mating types exhibited consider-
able differences in their electrophoretic karyotypes; a similar 
situation was observed in M. circinelloides (Diaz-Minguez 
et al. 1999).
RAPD analysis is also able to provide reproducible mark-
ers for strain identification. This method was previously 
used to establish specific PCR products able to differentiate 
between strains of several non-pathogenic zygomycete spe-
cies, such as P. parasitica (Burmester and Wöstemeyer 1994), 
M. piriformis (Papp et al. 1997), M. genevensis (Vágvölgyi 
et al. 2001) or Gilbertella persicaria (Papp et al. 2001). 
RAPD analysis of Rhizomucor strains showed R. miehei to 
be genetically more homogeneous than the diverse R. pusillus 
(Vastag et al. 1999, 2000). These results strongly supported 
the observations of the earlier studies based on isoenzyme 
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analysis and carbon source assimilation assay (Vastag et al. 
1997, 1998b). RAPD and the isoenzyme markers described 
in these works could be utilized in further studies to iden-
tify clinical and environmental isolates of R. miehei and R. 
pusillus and to check the accuracy of the original species 
identifications (Lukács et al. 2004b; Papp et al. 2004). The 
intraspecific variability of Rhizopus stolonifer and R. oryzae 
species was also examined by the RAPD method (Vágvölgyi 
et al. 2004a). Although only a few R. oryzae strains were in-
volved in that study, the RAPD analysis appeared to support 
the unity of the species R. oryzae, which was established with 
the incorporation of about 30 strains originally described as 
independent species.
Molecular diagnostics
All types of infections caused by the zygomycetes are no-
torious as being difficult to diagnose and treat. Diagnosis in 
an early phase of the infection is essential for a successful 
outcome of zygomycoses. Recent attempts of diagnosis, 
based on the molecular and serologic techniques, are still in 
the experimental phase. In an early effort to apply molecular 
methods for diagnosis, 18S rDNA sequences with SSCP 
patterns were established to distinguish Rhizopus infections 
from those caused by other fungi (Walsh et al. 1995). Strains 
of Rhizopus, Rhizomucor, Cunninghamella, Zygorhynchus 
and Mucor, together with several clinically important non-
zygomycete species, were involved in the development of a 
broad-range PCR assay (Van Burik et al. 1998). This method 
was optimized to detect fungal rDNA directly in the blood of 
patients, using long PCR probes. Although this non-specific 
assay is able to amplify the marker sequences of a broad range 
of fungal species, Rhizomucor and Cunninghamella proved to 
be non-detectable with the primers constructed in that study. 
The first significant advance in the development of a DNA-
based identification method was the determination of 18S 
and 28S rDNA sequences from 42 zygomycetes involving 
the most common opportunistic pathogenic species (Voigt 
et al. 1999). Those authors designed 13 taxon-specific PCR 
primer pairs based on the 28S rDNA sequences to resolve the 
clinically most important zygomycetes, including different 
species of Mucor, Rhizopus, Rhizomucor, Absidia, Cokeromy-
ces, Cunninghamella, Basidiobolus and Conidiobolus. Later, 
Wu et al. (2003) constructed a set of hybridization probes to 
detect the 18S rDNA of Mucor and Rhizopus species. Clinical 
strains of Mucor, Rhizopus, Rhizomucor and Cokeromyces 
were recently involved in an in vitro test of the commercially 
available MicroSeq D2 large subunit rDNA fungal sequencing 
kit (Applied Biosystems), which proved to be useful for the 
detection of these fungi (Hall et al. 2004).
Genetic transformation systems
The approaches most commonly used to examine the genetic 
background of pathogenic fungi are gene isolation, and the 
analysis of gene expression and gene disruption. The avail-
ability of an effective transformation system is a basic require-
ment for this type of molecular study.
The genetic transformation of a zygomycete fungus was 
first reported by van Heeswijck and Roncero (1984). They 
transformed a leucine auxotrophic strain of M. circinelloides, 
using a plasmid which harboured the α−isopropylmalate 
dehydrogenase gene (leuA). Their results have led to this 
species becoming a model organism for molecular studies on 
the class Zygomycetes during the past 20 years. Transforma-
tion procedures have additionally been elaborated for other 
zygomycetes, such as A. glauca (Wöstemeyer et al. 1987), R. 
pusillus (Wada et al. 1996, Yamazaki et al. 1999), R. miehei 
(Lukács et al. 2003, 2004a; Monfort et al. 2003; Vágvölgyi 
et al. 2004b), Rhizopus niveus (Yanai et al. 1990, 1991; Liou 
et al. 1992; Takaya et al. 1996), R. delemar (Horiuchi et al. 
1995) and R. oryzae (Skory 2002, 2004; Michielse et al. 
2003).
Mucor transformation protocols have traditionally been 
based on the CaCl
2
/PEG-mediated methodology and neces-
sitate protoplast formation from hyphae of young colonies 
or from germinating sporangiospores. The PEG-mediated 
transformation or electroporation of zygomycetes allows 
high-frequency transformations, but the introduced DNA 
remains almost exclusively extrachromosomal, replicating 
autonomously in the transformants (van Heeswijck and Ron-
cero 1984; Revuelta and Jayaram 1986; Anaya and Roncero 
1991; Iturriaga et al. 1992; Benito et al. 1995; Velayos et al. 
1998; Wolf and Arnau 2002; Ács et al. 2003a; Papp et al. 
2003b, 2005). In several cases, such transformants exhibit 
low mitotic stability. At times, integration in the genome 
can also be forced in these systems with the application of 
strong selection marker (Arnau et al. 1991; Arnau and Stro-
man 1993; Wada et al. 1996; Yamazaki et al. 1999) or the use 
of linear DNA fragments containing homologous flanking 
regions to drive the integration (Papp et al. 2002), but this is 
not the normal fate of the DNA introduced in these fungi. As 
a consequence, the genetic modification of the zygomycetes 
is generally hampered by the lack of an efficient integrative 
transformation system. To resolve this problem, the develop-
ment of Agrobacterium tumefaciens-mediated transformation 
systems has been started for some zygomycetes, e.g. R. oryzae 
(Michielse et al. 2004), R. miehei (Monfort et al. 2003) and M. 
circinelloides (Nyilasi et al. 2003, 2005a), in order to achieve 
stable integrative transformant strains.
Most of the transformation systems involve auxotrophy 
complementation to select for the transformants. The most 
frequently used markers are the α−isopropylmalate dehy-
drogenase (leuA or leu1) and orotidine-5-monophosphate 
decarboxylase (pyrG or pyr4) genes, which complement 
leucine and uracil auxotrophy, respectively (van Heeswijck 
and Roncero 1984; Benito et al. 1995; Michielse et al. 2002; 
Wolf and Arnau 2002; Skory 2004). However, these selection 
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methods have the drawback that a stable auxotrophic mutant 
first has to be isolated from each strain that it is desired to 
transform. Dominant selection markers would make possible 
the direct transformation of wild-type strains. Unfortunately, 
most of the zygomycetes tested so far are highly resistant 
to various antibiotics. For example, M. circinelloides was 
reported to be resistant to hygromycin B, geneticin, nemoy-
cin, oligomycin and benomyl (van Heeswijck et al. 1988). A 
method was recently developed for the hygromycin B-based 
selection of Mucor transformants: the sensitivity of the fungus 
was increased by the addition of rose bengal and dichloran 
to the culture medium (Fig. 1; Ács et al. 2003b; Nyilasi et 
al. 2005a).
To achieve heterologous gene expression in a host, it is 
usually necessary to combine the foreign gene with an ad-
equate regulatory sequence of the host. Promoter sequences of 
the glyceraldehyde-3-phosphate dehydrogenase genes (gpd) 
have been widely used for the construction of expression 
vectors in different yeasts and filamentous fungi. These genes 
have also been isolated and characterized from a few zygo-
mycetes: M. circinelloides (Ács et al. 2002; Wolf and Arnau 
2002) and R. miehei (Ács et al. 2003c; Vastag et al. 2004). 
The 5’ flanking region of Mucor gpd1 has been applied as a 
strong and regulated promoter in an expression study (Larsen 
et al. 2004). With this same sequence, a dominant selection 
marker-based system was elaborated by Appel et al. (2004), 
who constructed a plasmid containing the Tn-5-derived kana-
mycin resistance gene combined with the promoter sequence 
of Mucor gpd1.
Identification of virulence factors
Thermotolerance, the production of efficient proteolytic, gly-
cosidic and lipolytic extracellular enzymes (Ribes et al. 2000), 
siderophore production and an efficient iron transport system 
(Nyilasi et al. 2005b) have been suggested as the most likely 
virulence factors for opportunistic pathogenic zygomycetes. 
The isolation, cloning and disruption of a gene is an efficient 
means of analyzing the pathogenicity of a fungus and of 
determining and verifying possible virulence factors. Numer-
ous genes encoding lipases, proteases and glycosidases have 
been isolated in the cases of Mucor, Rhizopus, Rhizomucor 
and other zygomycetes, but whether they play any role in the 
pathogenic processes remains unknown (Ribes et al. 2000). 
A high-affinity iron permease gene (rFTR1) of R. oryzae 
was recently cloned and studies to analyse its function were 
started by Fu et al. (2004). The transformation of the rFTR 
gene to S. cerevisiae partially restored the ability of an ftr1 
null mutant to grow on an iron-limited medium. Null mutant 
strains of Candida albicans, produced by gene disruption of 
the homologous CaFTR gene, previously displayed reduced 
virulence as compared with the wild-type strains in animal 
models (Ramanan et al. 2000). However, similar studies have 
not yet been reported with the Rhizopus gene. A homologous 
FTR gene of R. miehei and vector construction to produce 
null mutant strains for virulence studies were reported by 
Nyilasi et al. (2005c).
In the past year, sequencing of the genome of the R. 
oryzae clinical isolate RA99-880 was completed and the se-
quence assembly was published on the web by the Rhizopus 
oryzae Sequencing Project (Broad Institute of Harvard and 
MIT 2004; http://www.broad.mit.edu). An acceleration of 
molecular studies on the pathogenicity of the zygomycetes 
can be expected in consequence of this result.
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